Topics

Ark Biosciences Company Profile

10:48 EDT 21st July 2019 | BioPortfolio

Ark Biosciences is a privately held, clinical-stage global biotechnology company with its corporate office located in ZhangJiang Hi-Tech Park in Shanghai, its R&D Center in Suzhou Biobay, China, and offices in the United States, Australia, and Switzerland. Ark Biosciences has its own active R&D programs and programs in collaboration with external partners. Through these efforts, Ark Biosciences aims to be a global biotechnology company, discovering and developing innovative drugs for treatment of viral infections and respiratory diseases. For more information, please visit: www.arkbiosciences.com


News Articles [651 Associated News Articles listed on BioPortfolio]

AUM Biosciences looks to advance anti-cancer molecule to Phase 2 later this year

AUM Biosciences CEO Vishal Doshi sat down with Proactive Investors at the BIO CEO and Investor Conference in New York. AUM Biosciences is a Singapore-based oncology-focused biotech company.

AUM Biosciences to develop Inflection’s cancer therapy

Biotechnology firm AUM Biosciences has entered a global licence agreement for Inflection Biosciences’ series of PIM/PI3K/mTOR inhibitor molecules. Under the...Read More... The post AUM Biosciences t...

Life Biosciences LLC leads strategic investment in Prana

(Life Biosciences) Prana Biotechnology Ltd (ASX: PBT, NASDAQ: PRAN) ('Prana' or 'the Company') has today announced that it has entered into a securities purchase agreement for a lead investment by Bos...

Curriculum Reforms in Uganda Integrate Modern Biosciences

Years of relentless efforts led by Uganda Biosciences Information Center (UBIC) to integrate modern biosciences into Uganda's middle/secondary schools' curriculum were finally rewarded. Uganda's Minis...

Caladrius Biosciences, Inc.: Caladrius Biosciences announces Purchase Agreement with Lincoln Park Capital for up to $26 million

BASKING RIDGE, NJ / ACCESSWIRE / March 14, 2019 / Caladrius Biosciences, Inc. (NASDAQ: CLBS) ('Caladrius' or the 'Company'), a late-stage therapeutics development biopharmaceutical company committe...

Caladrius Biosciences, Inc.: Caladrius Biosciences Reports 2018 Fourth Quarter and Year End Financial Results

Conference call begins today at 4:30 p.m. Eastern time BASKING RIDGE, NJ / ACCESSWIRE / March 14, 2019 / Caladrius Biosciences, Inc. (NASDAQ: CLBS) ("Caladrius" or the "Company"), a late-stage ther...

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Genocea Biosciences on Top

Last week's top risers were Genocea Biosciences, Outlook Therapeutics, Hoth Therapeutics, Aveo Oncology and Evofem Biosciences. The post 5 Top Weekly NASDAQ Biotech and Pharma Stocks: Genocea Bioscien...

Tosoh Boosts Biosciences with Semba Buy

Japan’s Tosoh has strengthened and expanded its bioscience business following the acquisition of a 33.3% stake in Semba Biosciences. Financial details were not disclosed. Headquartered in Madiso...

Drugs and Medications [33 Associated Drugs and Medications listed on BioPortfolio]

Eptifibatide [amneal biosciences]

These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION . EPTIFIBATIDE injection,...

Natelle one [meda pharmaceuticals]

natelleONE

Isoproterenol hydrochloride [amneal biosciences llc]

Isoproterenol Hydrochloride Injection, USP Rx only Sterile Injection

Spherusol [nielsen biosciences, inc.]

These highlights do not include all the information needed to use Spherusol safely and effectively. See full prescribing information for Spherusol . Coccidioides immitis Spherule-Derived Skin Test Ant...

Natelle one [azur pharma, inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

Clinical Trials [11 Associated Clinical Trials listed on BioPortfolio]

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Rheumatoid Arthritis

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

A Registry of Patients With Primary Choroidal Melanoma (CM) or Indeterminate Lesions (ILs)

The purpose of this observational research study is to follow participants who have been treated with either AU-011 or observation and/or received standard of care therapy while participat...

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Companies [390 Associated Companies listed on BioPortfolio]

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

DaVinci Biosciences LLC

DaVinci Biosciences LLC is a privately held company dedicated to advancing therapies that improve the quality of life for individuals suffering from trauma, disease and degenerative disorders. Through...

Ark Biosciences

Ark Biosciences is a privately held, clinical-stage global biotechnology company with its corporate office located in ZhangJiang Hi-Tech Park in Shanghai, its R&D Center in Suzhou...

More Information about "Ark Biosciences" on BioPortfolio

We have published hundreds of Ark Biosciences news stories on BioPortfolio along with dozens of Ark Biosciences Clinical Trials and PubMed Articles about Ark Biosciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ark Biosciences Companies in our database. You can also find out about relevant Ark Biosciences Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record